Immunopathogenesis of infection with the visceralizing Leishmania species
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mauricio, 2000, The strange case of Leishmania chagasi, Parasitol Today, 16, 188, 10.1016/S0169-4758(00)01637-9
Noyes, 1997, Leishmania chagasi: genotypically similar parasites from Honduras cause both visceral and cutaneous leishmaniasis in humans, Exp Parasitol, 85, 264, 10.1006/expr.1996.4133
Mebrahtu, 1993, Human cutaneous leishmaniasis caused by Leishmania donovani s.l. in Kenya, Trans R Soc Trop Med Hyg, 87, 598, 10.1016/0035-9203(93)90101-U
Ponce, 1991, Leishmania donovani chagasi: new clinical variant of cutaneous leishmaniasis in Honduras, Lancet, 337, 67, 10.1016/0140-6736(91)90734-7
Barral, 1991, Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease, Am J Trop Med Hyg, 44, 536, 10.4269/ajtmh.1991.44.536
Jones, 2000, IL-4 independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection, J Immunol, 165, 364, 10.4049/jimmunol.165.1.364
Ji, 2003, Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis, Infect Immun, 71, 4278, 10.1128/IAI.71.8.4278-4288.2003
Mosmann, 1989, Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties, Annu Rev Immunol, 7, 145, 10.1146/annurev.iy.07.040189.001045
Heinzel, 1991, Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis, Proc Natl Acad Sci USA, 88, 7011, 10.1073/pnas.88.16.7011
Scott, 1988, Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens, J Exp Med, 168, 1675, 10.1084/jem.168.5.1675
Scott, 1993, IL-12: initiation cytokine for cell-mediated immunity, Science, 260, 496, 10.1126/science.8097337
Guler, 1996, Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development, Science, 271, 984, 10.1126/science.271.5251.984
Jones, 1998, Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major, Infect Immun, 66, 3818, 10.1128/IAI.66.8.3818-3824.1998
Launois, 1999, New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice, Microbes Infect, 1, 59, 10.1016/S1286-4579(99)80015-X
Launois, 1997, IL-4 rapidly produced by Vβ4 Vα8 CD4+ T Cells Instructs Th2 development and susceptibility to Leishmania major in BALB/c mice, Immunity, 6, 541, 10.1016/S1074-7613(00)80342-8
Julia, 1996, Resistance to Leishmania major induced by tolerance to a single antigen, Science, 274, 421, 10.1126/science.274.5286.421
Barbosa, 1987, The pathology of experimental visceral leishmaniasis in resistant and susceptible lines of inbred mice, Braz J Med Res, 20, 63
Ghosh, 1987, Infection pattern of leishmaniasis in hamsters produced by recent isolates from kala-azar patients in India, Indian J Med Res, 86, 14
Melby, 2001, The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of prominent Th1-like cytokine response, J Immunol, 166, 1912, 10.4049/jimmunol.166.3.1912
Sartori, 1991, Immune complex glomerulonephritis in experimental kala-azar II: detection and characterization of parasite antigens and antibodies eluted from kidneys of Leishmania donovani-infected hamsters, Clin Exp Immunol, 87, 386, 10.1111/j.1365-2249.1992.tb03007.x
Gorczynski, 1982, Nature of resistance to leishmaniasis in experimental rodents, Dev Comp Immunol, 6, 199, 10.1016/S0145-305X(82)80003-7
Mock, 1985, Genetic control of systemic Leishmania major infections: dissociation of intrahepatic amastigote replication from control by the Lsh gene, Infect Immun, 50, 588, 10.1128/IAI.50.2.588-591.1985
Vidal, 1993, Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg, Cell, 73, 469, 10.1016/0092-8674(93)90135-D
Melby, 2001, Leishmania donovani: evoluation and architecture of the splenic cellular immune response related to control of infection, Exp Parasitol, 99, 17, 10.1006/expr.2001.4640
Wilson, 1996, Local suppression of IFN-γ in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi, J Immunol, 156, 2231, 10.4049/jimmunol.156.6.2231
Murray, 1999, Granulomatous inflammation: host antimicrobial defense in the tissues in visceral leishmaniasis, 977
Stern, 1988, Role of L3T4+ and LYT-2+ cells in experimental visceral leishmaniasis, J Immunol, 140, 3971, 10.4049/jimmunol.140.11.3971
Tumang, 1994, Role and effect of TNF-α in experimental visceral leishmaniasis, J Immunol, 153, 768, 10.4049/jimmunol.153.2.768
Wilson, 2002, The TGF-β response to Leishmania chagasi in the absence of IL-12, Eur J Immunol, 32, 3556, 10.1002/1521-4141(200212)32:12<3556::AID-IMMU3556>3.0.CO;2-Q
Engwerda, 1998, Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani, Eur J Immunol, 28, 669, 10.1002/(SICI)1521-4141(199802)28:02<669::AID-IMMU669>3.0.CO;2-N
Kaye, 1991, Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis, J Immunol, 146, 2763, 10.4049/jimmunol.146.8.2763
Lehmann, 2000, The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice, J Interferon Cytokine Res, 20, 63, 10.1089/107999000312748
Miralles, 1994, Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis, Infect Immun, 62, 1058, 10.1128/IAI.62.3.1058-1063.1994
Satoskar, 1995, Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection, Infect Immun, 63, 4894, 10.1128/IAI.63.12.4894-4899.1995
Wilson, 1987, Early histopathology of experimental infection with Leishmania donovani in hamsters, J Parasitol, 73, 55, 10.2307/3282344
Ahmed, 2003, Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis, Infect Immun, 71, 401, 10.1128/IAI.71.1.401-410.2003
Squires, 1990, Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice, Infect Immun, 58, 3893, 10.1128/IAI.58.12.3893-3898.1990
Squires, 1989, Experimental visceral leishmaniasis: role of endogenous IFN-g in host defense and tissue granulomatous response, J Immunol, 143, 4244, 10.4049/jimmunol.143.12.4244
Engwerda, 2000, Organ-specific immune response associated with infectious disease, Immunol Today, 21, 73, 10.1016/S0167-5699(99)01549-2
Kaye, 2002, The immunology of visceral leishmaniasis: current status, 137
Belkaid, 2000, A natural model of Leishmania major infection reveals a prolonged ‘silent’ phase of parasite amplification in the skin before the onset of lesion formation and immunity, J Immunol, 165, 969, 10.4049/jimmunol.165.2.969
McElraith, 1988, The dynamics of granuloma formation in experimental visceral leishmaniasis, J Exp Med, 167, 1927, 10.1084/jem.167.6.1927
Murray, 1992, Acquired resistance and granuloma formation in experimental visceral leishmaniasis, J Immunol, 148, 1858, 10.4049/jimmunol.148.6.1858
Müller, 1992, Role of T cell subsets during the recall of immunologic memory to Leishmania major, Eur J Immunol, 22, 3063, 10.1002/eji.1830221206
Wilson, 1998, The importance of transforming growth factor-β in murine visceral leishmaniasis, J Immunol, 161, 6148, 10.4049/jimmunol.161.11.6148
Park, 2002, The role of IL-12 in maintaining resistance to Leishmania major, J Immunol, 168, 5771, 10.4049/jimmunol.168.11.5771
Gorak, 1998, Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection, Eur J Immunol, 28, 687, 10.1002/(SICI)1521-4141(199802)28:02<687::AID-IMMU687>3.0.CO;2-N
Mauël, 1991, Nitrogen and oxygen metabolites and the killing of Leishmania by activated murine macrophages, Res Immunol, 7, 577, 10.1016/0923-2494(91)90106-S
Green, 1991, Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens, J Leuk Biol, 50, 93, 10.1002/jlb.50.1.93
Gantt, 2001, Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi, J Immunol, 167, 893, 10.4049/jimmunol.167.2.893
Janeway, 2001
Murphy, 1998, Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani, J Immunol, 161, 4153, 10.4049/jimmunol.161.8.4153
Gomes, 2001, The dual role of CTLA-4 in Leishmania infection, Trends Parasitol, 17, 487, 10.1016/S1471-4922(01)02038-4
Gomes, 2000, Transforming growth factor beta regulates CTLA-4 suppression of cellular immunity in murine Kala-Azar, J Immunol, 164, 2001, 10.4049/jimmunol.164.4.2001
Gorelik, 2000, TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression, J Immunol, 165, 4773, 10.4049/jimmunol.165.9.4773
Gorham, 1998, Low dose TGF-β attenuates IL-12 responsiveness in murine Th cells, J Immunol, 161, 1664, 10.4049/jimmunol.161.4.1664
Letterio, 1998, Regulation of immune responses by TGF-β, Annu Rev Immunol, 16, 137, 10.1146/annurev.immunol.16.1.137
Andrade, 1990, Bacterial infections in patients with visceral leishmaniasis, J Infect Dis, 162, 1354, 10.1093/infdis/162.6.1354
Badaro, 1996, rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis, J Infect Dis, 173, 758, 10.1093/infdis/173.3.758
Braz, 2002, The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infection, Am J Trop Med Hyg, 67, 344, 10.4269/ajtmh.2002.67.344
Badaro, 1986, New perspectives on a subclinical form of visceral leishmaniasis, J Infect Dis, 154, 1003, 10.1093/infdis/154.6.1003
Ho, 1983, Immunosuppression in Kenyan visceral leishmaniasis, Clin Exp Immunol, 51, 207
Badaro, 1986, A prospective study of visceral leishmaniasis in an endemic area of Brazil, J Infect Dis, 154, 639, 10.1093/infdis/154.4.639
Carvalho, 1992, Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi, J Infect Dis, 165, 535, 10.1093/infdis/165.3.535
Ghalib, 1995, IL-12 enhances Th1-type responses in human Leishmania donovani infections, J Immunol, 154, 4623, 10.4049/jimmunol.154.9.4623
Bacellar, 1996, Interleukin-12 restores interferon-γ production and cytotoxic responses in visceral leishmaniasis, J Infect Dis, 173, 1515, 10.1093/infdis/173.6.1515
Carvalho, 1989, Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated, J Clin Invest, 83, 860, 10.1172/JCI113969
Karp, 1993, In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma, J Clin Invest, 91, 1644, 10.1172/JCI116372
Ghalib, 1993, Interleukin 10 production correlates with pathology in human Leishmania donovani infections, J Clin Invest, 92, 324, 10.1172/JCI116570
Atta, 1998, Anti-Leishmania IgE antibodies: a marker of active disease in visceral leishmaniasis, Am J Trop Med Hyg, 59, 426, 10.4269/ajtmh.1998.59.426
Carvalho, 1994, Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis, J Immunol, 152, 5949, 10.4049/jimmunol.152.12.5949
Kemp, 1999, Leishmania-specific T cells expressing interferon-gamma (IFN-γ) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis, Clin Exp Immunol, 116, 500, 10.1046/j.1365-2249.1999.00918.x
Sang, 1999, Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis, J Infect Dis, 179, 743, 10.1086/314635
Van der Poll, 1995, Interleukin 6 during active visceral leishmaniasis and after treatment, Clin Immunol Immunopathol, 77, 111, 10.1016/0090-1229(95)90144-2
Barral-Netto, 1991, Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis, J Immunol, 147, 281, 10.4049/jimmunol.147.1.281
Nascimento, 2002, TGF-b in acute visceral leishmaniasis, Am J Trop Med Hyg, 67, 262
Jeronimo, 2000, Natural history of Leishmania (Leishmania) chagasi infection in northeastern Brazil: long term follow-up, Clin Infect Dis, 30, 608, 10.1086/313697
Jeronimo SMB, Braz RFS, Cheng C, Lacerda HG, Nascimento ET, Bezerra FL, et al. The spectrum of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil. Scand J Infect Dis; in press.
Mock, 1988, Hormonal modulation of sex differences in resistance to Leishmania major systemic infections, Infect Immun, 56, 3316, 10.1128/IAI.56.12.3316-3319.1988
Alexander, 2003, Sex differences and cross-immunity in DBA/2 mice infected with L. mexicana and L. major, Parasitology, 96, 297, 10.1017/S0031182000058303
Travi, 2002, Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp, Infect Immun, 70, 2288, 10.1128/IAI.70.5.2288-2296.2002
Anuradha, 1990, Sex-influenced population kinetics of Leishmania donovani in hamsters, Indian J Exp Biol, 28, 876
Brittingham, 1995, Role of Leishmania protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis, J Immunol, 155, 3102, 10.4049/jimmunol.155.6.3102
Hey, 1994, The major surface glycoprotein (gp63) from Leishmania major and Leishmania donovani cleaves CD4 molecules on human T cells, J Immunol, 152, 4542, 10.4049/jimmunol.152.9.4542
Corradin, 1999, MARCKS-related protein (MRP) is a substrate for the Leishmania major surface protease leishmanolysin (GP63), J Biol Chem, 274, 25411, 10.1074/jbc.274.36.25411
Descoteaux, 1998, Leishmania cysteine proteinases: virulence factors in quest of a function, Parasitol Today, 14, 220, 10.1016/S0169-4758(98)01241-1
Bart, 1997, Cathepsin B-like cysteine proteinase-deficient mutants of Leishmania mexicana, Mol Biochem Parasitol, 88, 53, 10.1016/S0166-6851(97)00072-8
Frame, 2000, Analysis of the roles of cysteine proteinases of Leishmania mexicana in the host-parasite interaction, Parasitology, 121, 367, 10.1017/S0031182099006435
Alexander, 1998, Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response, J Immunol, 161, 6794, 10.4049/jimmunol.161.12.6794
Maekawa, 1998, Switch of CD4+ T Cell Differentiation from Th2 to Th1 by treatment of Cathepsin B inhibitor in experimental leishmaniasis, J Immunol, 161, 2120, 10.4049/jimmunol.161.5.2120
Das, 2001, Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T Cell response, J Immunol, 166, 4020, 10.4049/jimmunol.166.6.4020
Hirsch, 1997, In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor β, Proc Natl Acad Sci USA, 94, 3926, 10.1073/pnas.94.8.3926
Barral-Netto, 1992, Transforming growth factor-β in leishmanial infection: a parasite escape mechanism, Science, 257, 545, 10.1126/science.1636092
Barral, 1993, Transforming growth factor β as a virulence mechanism for Leishmania braziliensis, Proc Natl Acad Sci USA, 90, 3442, 10.1073/pnas.90.8.3442
Li, 1999, Anti-TGF-β treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production, J Immunol, 162, 974, 10.4049/jimmunol.162.2.974
Rodrigues, 1998, Transforming growth factor β and immunosuppression in experimental visceral leishmaniasis, Infect Immun, 66, 1233, 10.1128/IAI.66.3.1233-1236.1998
Somanna, 2002, Functional analysis of cathepsin B-like cysteine proteases from Leishmania donovani complex: evidence for the activation of latent transforming growth factor beta, J Biol Chem, 277, 25305, 10.1074/jbc.M203034200
Gantt, 2003, Activation of TGF-β by Leishmania chagasi: importance for parasite survival in macrophages, J Immunol, 170, 2613, 10.4049/jimmunol.170.5.2613
Ilg, 2000, Proteophosphoglycans of Leishmania, Parasitol Today, 16, 489, 10.1016/S0169-4758(00)01791-9
Cunningham, 2002, Parasitic adaptive mechanisms in infection by Leishmania, Exp Mol Pathol, 72, 132, 10.1006/exmp.2002.2418
Panaro, 1995, Parasite escape mechanisms: the role of Leishmania lipophosphoglycan on the human phagocyte functions. A review, Immunopharmacol Immunotoxicol, 17, 595, 10.3109/08923979509016390
Turco, 1992, The lipophosphoglycan of Leishmania parasites, Annu Rev Microbiol, 46, 65, 10.1146/annurev.mi.46.100192.000433
Liew, 1991, Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages, Eur J Immunol, 21, 3009, 10.1002/eji.1830211216
Diefenbach, 1998, Type 1 interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite, Immunity, 8, 77, 10.1016/S1074-7613(00)80460-4
Shiloh, 1999, Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase, Immunity, 10, 29, 10.1016/S1074-7613(00)80004-7
Murray, 1999, Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani, J Exp Med, 189, 741, 10.1084/jem.189.4.741
Liew, 1997, Cytokines and nitric oxide as effector molecules against parasitic infections, Philos Trans R Soc Lond [Biol], 352, 1311, 10.1098/rstb.1997.0115
Murray, 1992, l-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes, J Infect Dis, 165, 513, 10.1093/infdis/165.3.513
Vouldoukis, 1995, The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FceRII/CD23 surface antigen, Proc Natl Acad Sci USA, 92, 7804, 10.1073/pnas.92.17.7804
Diefenbach, 1999, Requirement for type 2NO synthase for IL-12 signaling in innate immunity, Science, 284, 951, 10.1126/science.284.5416.951
Koay, 2001, Impaired pulmonary NF-κB activation in response to lipopolysaccharide in NADPH oxidase-deficient mice, Infect Immun, 69, 5991, 10.1128/IAI.69.10.5991-5996.2001
Devadas, 2002, Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and Fas ligand expression, J Exp Med, 195, 59, 10.1084/jem.20010659
Iniesta, 2001, The inhibition of arginase by N-hydroxy-l-arginine controls the growth of Leishmania inside macrophages, J Exp Med, 193, 777, 10.1084/jem.193.6.777
Roberts, 2004, Arginase plays a pivoatal role in polyamine precursor metabolism in Leishmania: characterizatrion of gene deletion mutants, J Biol Chem, 279, 23668, 10.1074/jbc.M402042200
Nandan, 1999, Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani, Infect Immun, 67, 4055, 10.1128/IAI.67.8.4055-4063.1999
Nandan, 1995, Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1, Infect Immun, 63, 4495, 10.1128/IAI.63.11.4495-4500.1995
Forget, 2001, Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis, J Immunol, 31, 3185
Harrison, 1986, Reciprocal relationships between undernutrition and the parasitic disease visceral leishmaniasis, Rev Infect Dis, 8, 447, 10.1093/clinids/8.3.447
Anstead, 2001, Matlnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection, Infect Immun, 69, 4709, 10.1128/IAI.69.8.4709-4718.2001
Alvar, 1994, Leishmaniasis and the AIDS co-infection: the Spanish example, Parasitol Today, 10, 160, 10.1016/0169-4758(94)90270-4
Evans, 1995, Short report: extended follow-up of the natural history of persons infected with Leishmania chagasi, Am J Trop Med Hyg, 53, 360, 10.4269/ajtmh.1995.53.360
Bradley, 1979, Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse, Clin Exp Immunol, 37, 7
Blackwell, 1980, Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice, Nature, 283, 72, 10.1038/283072a0
Blackwell, 1996, Genetic susceptibility to leishmanial infections: studies in mice and man, Parasitology, 112, S67, 10.1017/S0031182000076678
Roberts, 1993, Mapping of genes controlling Leishmania major infection in CXS recombinant inbred mice, Eur J Immunogenet, 20, 349, 10.1111/j.1744-313X.1993.tb00154.x
Gorham, 1996, Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses, Proc Natl Acad Sci USA, 93, 12467, 10.1073/pnas.93.22.12467
Demant, 1996, Resistance to Leishmania major in mice, Science, 274, 1392, 10.1126/science.274.5291.1392
Beebe, 1997, Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice, Immunity, 6, 551, 10.1016/S1074-7613(00)80343-X
Roberts, 1999, Chromosomes X, 9, and the H2 locus interact epistatically to control Leishmania major infection, Eur J Immunol, 29, 3047, 10.1002/(SICI)1521-4141(199909)29:09<3047::AID-IMMU3047>3.0.CO;2-L
Roberts, 1997, Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9, J Exp Med, 185, 1705, 10.1084/jem.185.9.1705
Lipoldovà, 2000, Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes, Genes Immun, 1, 200, 10.1038/sj.gene.6363660
El Hassan, 1995, Recent observations on the epidemiology of kala-azar in the eastern and central states of the Sudan, Trop Geogr Med, 47, 151
Ibrahim, 1999, Kala-azar in a high transmission foci: an ethnic and geographical dimension, Am J Trop Med Hyg, 61, 941, 10.4269/ajtmh.1999.61.941
Alcais, 1997, Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population, Am J Hum Genet, 61, 968, 10.1086/514882
Shaw, 1995, Human genetic susceptibility and infection with Leishmania peruviana, Am J Hum Genet, 57, 1159
Feitosa, 1999, Genetic causes involved in Leishmania chagasi infection in Northeastern Brazil, Genet Mol Biol, 22, 1, 10.1590/S1415-47571999000100001
Peacock, 2001, Genetic epidemiology of visceral leishmaniasis in Northeastern Brazil, Genet Epidemiol, 20, 383, 10.1002/gepi.8
Blackwell, 1998, Genetics of host resistance and susceptibility to intramacrophage pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in North-eastern Brazil, Int J Parasitol, 28, 21, 10.1016/S0020-7519(97)00175-6
Cabrera, 1995, Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis, J Exp Med, 182, 1259, 10.1084/jem.182.5.1259
Bucheton, 2003, Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region, Genes Immun, 4, 104, 10.1038/sj.gene.6363927
Mohamed, 2003, Genetic susceptibilty to visceral leishmaniasis in the Sudan: linkage and association with IL4 and IFNGR1, Genes Immun, 4, 351, 10.1038/sj.gene.6363977
Bucheton, 2003, A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar, Am J Hum Genet, 73, 1052, 10.1086/379084
Karplus, 2002, An association between the TNF locus and the clinical outcome of Leishmania chagasi infection, Infect Immun, 70, 6919, 10.1128/IAI.70.12.6919-6925.2002
Petzl-Erler, 1991, Association of mucosal leishmaniasis with HLA, Hum Immunol, 32, 254, 10.1016/0198-8859(91)90088-Q
Barbier, 1987, Susceptibility to human cutaneous leishmaniasis and HLA, Gm, Km markers, Tissue Antigens, 30, 63, 10.1111/j.1399-0039.1987.tb01598.x
Lara, 1991, Immunogenetics of human American cutaneous leishmaniasis, Hum Immunol, 30, 129, 10.1016/0198-8859(91)90081-J
Peacock, 2002, Genetic analysis of multicase families of visceral leishmaniasis in Northeastern Brazil: no major role for class II or class III regions of HLA, Genes Immun, 3, 358
McGuire, 1994, Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria, Nature, 371, 508, 10.1038/371508a0
Verweij, 1999, Tumor necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis, Ann Rhem Dis, 58, 120
Wilson, 1997, Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation, Proc Natl Acad Sci USA, 94, 3195, 10.1073/pnas.94.7.3195
Bouma, 1996, Secretion of tumour necrosis factor α and lymphtoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease, Scand J Immunol, 43, 456, 10.1046/j.1365-3083.1996.d01-65.x
Hajeer, 2000, TNF-a gene polymorphism: clinical and biological implications, Microsc Res Tech, 50, 216, 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q
Pearson, 1995, Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis, 2428